CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Imbed Biosciences' DualGuard™ Silver-Gallium Matrix Safety Study Now Registered on ClinicalTrials.gov

Trial StartDualGuard™ Silver-Gallium MatrixPositive
AI Analysis

Summary

Imbed Biosciences announced the clinical trial registration (NCT07695688) for its DualGuard Silver-Gallium Matrix safety study, designed to address biofilm challenges in wound care applications.

Clinical Trial Data

Importance:3/10
Sentiment:
0.30
clinical trialsafety studyantimicrobialwound carebiofilmSAMatrix platform

Read the original article

Published by PR Newswire Biotech on October 1, 2026 1:54 PM

Read Original